Journal of Neurology and Neuroscience

  • ISSN: 2171-6625
  • Journal h-index: 18
  • Journal CiteScore: 4.35
  • Journal Impact Factor: 3.75
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • The Global Impact Factor (GIF)
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Scientific Journal Impact Factor (SJIF)
  • Euro Pub
  • Google Scholar
  • Secret Search Engine Labs
Share This Page


Long-term Follow-up of Relapsing-Remitting Multiple Sclerosis

Loren A. Rolak, Brent Olson and Po-Huang ChyoU

Background: Although many studies have shown shortterm benefits of disease modifying drugs (DMDs) in reducing relapse rates in patients with multiple sclerosis (MS), the data about long-term effects is more scarce and less certain. The objective of this study was to determine the natural history of relapsing-remitting multiple sclerosis, both treated and untreated, in a real-world setting.
Methods: We analyzed relapse rates and disability scores in 891 patients in a specialized MS clinic followed in a longitudinal database for as long as 21 years. We compared 370 patients who never received treatment with 521 who had prolonged therapy with one of the various DMDs.
Findings: Most patients with relapsing-remitting disease did well, and accumulation of disability was slow regardless of treatment. Among patients followed 10 years or more, mean [median]Expanded Disability Status Scale scores were 3.0 [2.0] among untreated patients and 4.2 [4.3] among treated patients (p=0.0032).There was no correlation between number of relapses and disability.
Conclusion: Many patients have a mild course and accumulate little or no disability. Patients with more severe disease continue to worsen despite therapy but often still do well.